| 期 |
栏目 |
标题 |
文件 |
| 卷 90, 编号 6 (2018) |
Editorial |
Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration |
(Rus)
|
| 卷 90, 编号 6 (2018) |
Editorial |
Quality of life of chronic kidney disease patients on renal replacement therapy |
(Rus)
|
| 卷 92, 编号 6 (2020) |
Original articles |
Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2–5D |
(Rus)
|
| 卷 91, 编号 6 (2019) |
Articles |
Low protein diet with essential amino acids ketoanalogues combination can affect serum FGF-23 and Klotho levels in chronic kidney disease 3b-4 stages patients: randomized pilot study |
(Rus)
|
| 卷 91, 编号 6 (2019) |
Articles |
Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease |
(Rus)
|
| 卷 91, 编号 6 (2019) |
Articles |
Hepatitis C virus - related cryoglobulinemic vasculitis with renal involvement current possibilities of diagnostic and treatment |
(Rus)
|
| 卷 93, 编号 6 (2021) |
Original articles |
Effect of vitamin D receptor activators on serum Klotho levels in 3b–4 stages chronic кidney disease patients: a prospective randomized study |
(Rus)
|
| 卷 94, 编号 6 (2022) |
Original articles |
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study |
(Rus)
|
